Citations

Showing 10 of 108094 citations.

Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID‐19: A Propensity Score‐Matched Cohort Analysis of the HOPE‐COVID‐19 Registry
Santoro, Francesco , Núñez‐Gil, Iván J. , Vitale, Enrica , Viana‐Llamas, María C. , Romero, Rodolfo , Maroun‐Eid, Charbel , Guzmãn, Gisela Feltes, Becerra‐Muñoz, Víctor Manuel , Rozas, Inmaculada Fernández, Uribarri, Aitor , Alfonso‐Rodríguez, Emilio , Aguado, Marcos Garcı́a, Huang, Jia , Castro‐Mejía, Alex F. , Prieto, Juan Fortunato García, Elola, Javier , Cerrato, Enrico , Signes‐Costa, Jaime , Mendez, Jorge Luis Jativa , Paeres, Carolina Espejo, Masjuan, Álvaro López, Marı́n, Francisco , El‐Battrawy, Ibrahim , Cortese, Bernardo , Pérez‐Villacastín, Julián , Castro Mejía, Alex Fernando , Cerrato, Enrico , Raposeiras-Roubin, Sergio , Jativa Mendez, Jorge Luis , Guerra, Federico , El-Battrawy, Ibrahim , Cortese, Bernardo , Ramakrishna, Harish , Perez-Villacastín, Julian , Fernandez-Ortiz, Antonio , Brunetti, Natale Daniele , Nuñez-Gil, Ivan Javier , Santoro, Francesco , Marín, Francisco , Viana-Llamas, María C , Becerra-Muñoz, Víctor , Uribarri, Aitor , Ugo, Fabrizio , Raposeiras‐Roubín, Sergio , Fernández‐Ortíz, Antonio

Mayo Clinic

Journal of the American Heart Association | June 22, 2022 | Volume: 11 | Issue: 13 | Pages: No page available

10.1161/jaha.121.024530 | PMID 35730631 Get It

Background COVID‐19 is an infectious illness, featured by an increased risk of thromboembolism. However, no standard antithrombotic therapy is currently recommended for patients hospitalized with COVID‐19. The aim of this study was to evaluate safety and efficacy of additional therapy with aspirin over prophylactic anticoagulation (PAC) in patients hospitalized with COVID‐19 and its impact on survival. Methods and Results A total of 8168 patients hospitalized for COVID‐19 were enrolled in a multicenter‐international prospective registry (HOPE COVID‐19). Clinical data and in‐hospital complications, including mortality, were recorded. Study population included patients treated with PAC or with PAC and aspirin. A comparison of clinical outcomes between patients treated with PAC versus PAC and aspirin was performed using an adjusted analysis with propensity score matching. Of 7824 patients with complete data, 360 (4.6%) received PAC and aspirin and 2949 (37.6%) PAC. Propensity‐score matching yielded 298 patients from each group. In the propensity score‐matched population, cumulative incidence of in‐hospital mortality was lower in patients treated with PAC and aspirin versus PAC (15% versus 21%, Log Rank P =0.01). At multivariable analysis in propensity matched population of patients with COVID‐19, including age, sex, hypertension, diabetes, kidney failure, and invasive ventilation, aspirin treatment was associated with lower risk of in‐hospital mortality (hazard ratio [HR], 0.62; [95% CI 0.42–0.92], P =0.018). Conclusions Combination PAC and aspirin was associated with lower mortality risk among patients hospitalized with COVID‐19 in a propensity score matched population compared to PAC alone.
Pathogenic mutations in the chromokinesin KIF22 disrupt anaphase chromosome segregation
Thompson, Alex F. , Blackburn, Patrick R. , Arons, Noah S, Stevens, Sarah N, Babovic‐Vuksanovic, Dusica , Lian, Jane B. , Klee, Eric W. , Stumpff, Jason , Klee, Eric W

Mayo Clinic

eLife | June 22, 2022 | Volume: 11 | Issue: No issue available | Pages: No page available

10.7554/elife.78653 | PMID 35730929 Get It

The chromokinesin KIF22 generates forces that contribute to mitotic chromosome congression and alignment. Mutations in the α2 helix of the motor domain of KIF22 have been identified in patients with abnormal skeletal development, and we report the identification of a patient with a novel mutation in the KIF22 tail. We demonstrate that pathogenic mutations do not result in a loss of KIF22’s functions in early mitosis. Instead, mutations disrupt chromosome segregation in anaphase, resulting in reduced proliferation, abnormal daughter cell nuclear morphology, and, in a subset of cells, cytokinesis failure. This phenotype could be explained by a failure of KIF22 to inactivate in anaphase. Consistent with this model, constitutive activation of the motor via a known site of phosphoregulation in the tail phenocopied the effects of pathogenic mutations. These results suggest that the motor domain α2 helix may be an important site for regulation of KIF22 activity at the metaphase to anaphase transition. In support of this conclusion, mimicking phosphorylation of α2 helix residue T158 also prevents inactivation of KIF22 in anaphase. These findings demonstrate the importance of both the head and tail of the motor in regulating the activity of KIF22 and offer insight into the cellular consequences of preventing KIF22 inactivation and disrupting force balance in anaphase.
Laser Oromaxillofacial Photobiomodulation Therapy: Molecular Mechanisms, Outcomes And Considerations
Fiani, Brian , Nathani, Karim Rizwan , Jarrah, Ryan , Nathani, Karim Rizwan

Mayo Clinic

Regenerative Medicine | June 22, 2022 | Volume: 17 | Issue: 9 | Pages: 611-615

10.2217/rme-2022-0091 | PMID 35730260 Get It

Home Parenteral and Enteral Nutrition
Bering, Jamie , DiBaise, John K.

Mayo Clinic

Nutrients | June 22, 2022 | Volume: 14 | Issue: 13 | Pages: 2558

10.3390/nu14132558 | PMID 35807740 Get It

While the history of nutrition support dates to the ancient world, modern home parenteral and enteral nutrition (HPEN) has been available since the 1960s. Home enteral nutrition is primarily for patients in whom there is a reduction in oral intake below the amount needed to maintain nutrition or hydration (i.e., oral failure), whereas home parenteral nutrition is used for patients when oral-enteral nutrition is temporarily or permanently impossible or absorption insufficient to maintain nutrition or hydration (i.e., intestinal failure). The development of home delivery of these therapies has revolutionized the field of clinical nutrition. The use of HPEN appears to be increasing on a global scale, and because of this, it is important for healthcare providers to understand all that HPEN entails to provide safe, efficacious, and cost-effective support to the HPEN patient. In this article, we provide a comprehensive review of the indications, patient requirements, monitoring, complications, and overall process of managing these therapies at home. Whereas some of the information in this article may be applicable to the pediatric patient, the focus is on the adult population.
Peri-Operative Management of Patients Undergoing Fenestrated-Branched Endovascular Repair for Juxtarenal, Pararenal and Thoracoabdominal Aortic Aneurysms: Preventing, Recognizing and Treating Complications to Improve Clinical Outcomes
Xodo, Andrea , D’Oria, Mario , Mendes, Bernardo C. , Bertoglio, Luca , Mani, Kevin , Gargiulo, Mauro , Budtz-Lilly, Jacob , Antonello, Michele , Pilon, Fabio , Milite, Domenico, Calvagna, Cristiano, Griselli, Filippo, Taglialavoro, Jacopo, Bassini, Silvia , Lindström, David , Mezzetto, Luca , Mendes, Bernardo, Lindstrom, David , Mezzetto, Luca , DeMartino, Randall, D'Oria, Mario , Veraldi, Gian Franco , Wanhainen, Anders , Gallitto, Enrico , Mastrorilli, Davide , Lepidi, Sandro , DeMartino, Randall R.

Mayo Clinic

Journal of Personalized Medicine | June 22, 2022 | Volume: 12 | Issue: 7 | Pages: 1018

10.3390/jpm12071018 | PMID 35887518 Get It

The advent and refinement of complex endovascular techniques in the last two decades has revolutionized the field of vascular surgery. This has allowed an effective minimally invasive treatment of extensive disease involving the pararenal and the thoracoabdominal aorta. Fenestrated-branched EVAR (F/BEVAR) now represents a feasible technical solution to address these complex diseases, moving the proximal sealing zone above the renal-visceral vessels take-off and preserving their patency. The aim of this paper was to provide a narrative review on the peri-operative management of patients undergoing F/BEVAR procedures for juxtarenal abdominal aortic aneurysm (JAAA), pararenal abdominal aortic aneurysm (PRAA) or thoracoabdominal aortic aneurism (TAAA). It will focus on how to prevent, diagnose, and manage the complications ensuing from these complex interventions, in order to improve clinical outcomes. Indeed, F/BEVAR remains a technically, physiologically, and mentally demanding procedure. Intraoperative adverse events often require prolonged or additional procedures and complications may significantly impact a patient’s quality of life, health status, and overall cost of care. The presence of standardized preoperative, perioperative, and postoperative pathways of care, together with surgeons and teams with significant experience in aortic surgery, should be considered as crucial points to improve clinical outcomes. Aggressive prevention, prompt diagnosis and timely rescue of any major adverse events following the procedure remain paramount clinical needs.
Succinct Cancer Clinical Trial Consent Forms in Rural Patients With Cancer: A Secondary Analysis of a Randomized, Double-Blinded study
Wieland, Jana, Satele, Daniel , Almodallal, Yahya , Novotny, Paul J. , Pritzl, Stephanie L., Mandrekar, Sumithra J. , Jatoi, Aminah , Novotny, Paul

Mayo Clinic

Journal of Patient Experience | June 22, 2022 | Volume: 9 | Issue: No issue available | Pages: No page available

10.1177/23743735221107242 | PMID 35756962 Get It

Rural patients are often underrepresented in cancer clinical trials. This is a secondary analysis of a study that tested short (2000 word) versus long (6000 word) consent forms with a focus on rurality. Among 240 patients, 89 (37%) were rural. Seventy-one (80%) rural and 117 (77%) nonrural patients signed a consent form of any length ( P = .68). Forty-one of 47 (87%) rural patients signed a short consent form; in contrast, 30 of 42 (71%) signed a long form. These trends suggest rural patients are more likely to sign short consent forms. Further study is indicated.
The Hospital Value‐Based Purchasing Program: Do hospitalists improve health care value
Spaulding, Aaron , Tafili, Aurora , Dunn, Ajani N., Hamadi, Hanadi , Dunn, Ajani, Spaulding, Aaron , Hamadi, Hanadi Y

Mayo Clinic

Journal of Hospital Medicine | June 22, 2022 | Volume: 17 | Issue: 7 | Pages: 517-526

10.1002/jhm.12892 | PMID 35729856 Get It

AbstractIntroductionAs healthcare organizations examine the associated benefits of employing a larger hospitalist workforce, there is a need to better understand the association with patients' quality, experience, and efficiency. However, there is a lack of information regarding how hospital use of hospitalists over time influences hospital scoring on quality programs, such as the Center for Medicare and Medicaid Services (CMS) Hospital Inpatient Value‐Based Purchasing (HVBP) Program. This study examines the association between hospitalist staffing between 2014 and 2019 and HVBP scores.MethodsWe used a cross‐sectional panel study design. Total Performance Score (TPS) and its domains were obtained from CMS from 2014 to 2019 and merged with the American Hospital Association Annual Survey Database. We utilized random‐effects multivariable panel regression models and zero‐inflated negative binomial regression to examine the association between the hospitalist‐staffing ratio and the HVBP Program. All models were adjusted for hospital characteristics.ResultsA total of 2126 hospitals were included in the study. The average ratio of hospitalists per staffed bed was 0.06, with a standard deviation of 0.15. This study suggests that hospitals that employ a higher percentage of hospitalists see improvement in their overall TPS (β = 5.40; p < .001), Patient Experience (β = 2.49; p <.05), and Efficiency (incidence‐rate ratio= 1.41; p < .001) domain. However, the Clinical Care domain was no different in organizations employing more hospitalists.ConclusionThere are benefits associated with TPS, Patient Experience, and Efficiency from employing hospitalists. Managers should seek opportunities to leverage hospitalists' expertise in providing care, particularly in improving care processes.
Nonmalignant Central Airway Obstruction: Options for Challenging Cases
Fernández-Bussy, Sebastián , Abia‐Trujillo, David

Mayo Clinic

Seminars in Respiratory and Critical Care Medicine | June 21, 2022 | Volume: 43 | Issue: 04 | Pages: 530-535

10.1055/s-0042-1747937 | PMID 35728604 Get It

AbstractBenign central airway obstruction is commonly referred as nonmalignant central airway obstruction (NMCAO). This is in part related to its lack of benign nature and significant life-quality impairment in patients. It is a pathologic entity with various etiologies and therefore a wide range of therapeutic options are available. Evidence regarding the optimal management that could provide a sustained restoration of airway patency is lacking. The lack of a common pathophysiologic pathway translating into a nonspecific symptom presenting as NMCAO has complicated treatment standardization and subsequently limited solid research to favor of one approach over another one. Our intent is to describe the limited evidence of the most utilized nonsurgical treatment for NMCAO as well as some upcoming promising therapeutic options such as mitomycin C injection, microdebrider, biodegradable stents, radiotherapy, Hybrid Knife, and endoluminal spray cryotherapy. Our goal with this manuscript is to motivate other authors to venture into prospective, multicenter, open-label trials aimed to describe long-term outcomes in patients with NMCAO.
How to Infuse Joy in Your Practice: Our Journey to Sustainable Well-Being
Stonnington, Cynthia M. , Leighton, Jonathan A. , Jones, Keith , Jones, Keith W.

Mayo Clinic

American Journal of Gastroenterology | June 21, 2022 | Volume: 117 | Issue: 11 | Pages: 1723-1727

10.14309/ajg.0000000000001892 | PMID 35973170 Get It

High-Grade Colonic Stricture After a Severe Case of COVID-19 Pneumonia
Jarvis, Nicholas R. , Mishra, Nitin

Mayo Clinic

The American Surgeon™ | June 21, 2022 | Volume: 89 | Issue: 12 | Pages: 6197-6199

10.1177/00031348221109811 | PMID 35728086 Get It

Extrapulmonary involvement of coronavirus-19 disease (COVID-19) is being documented and studied at an increasing frequency. Specifically, gastrointestinal involvement is hypothesized to occur due to cellular entry via the ACE2 receptor found in gastrointestinal epithelial cells, causing inflammation and symptoms such as abdominal pain, nausea/vomiting, and diarrhea. We present the case of a 45-year-old female with recent severe COVID-19 infection and early gastrointestinal symptoms who later presented with worsening abdominal pain, nausea, vomiting, and constipation after initial discharge. She was diagnosed with a large bowel obstruction and underwent urgent exploratory laparotomy, which revealed a stricture of the distal transverse colon. Following segmental resection, the patient experienced resolution of symptoms. We hypothesize that this patient’s colonic stricture arose secondary to severe COVID-19-induced bowel inflammation.